|
APOOL expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.27290003169168E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.03089999980988E-07 |
| Normal-vs-Stage2 |
5.278000E-03 |
| Normal-vs-Stage3 |
9.33010002590606E-09 |
| Normal-vs-Stage4 |
1.18100000001675E-07 |
| Stage1-vs-Stage2 |
2.752400E-01 |
| Stage1-vs-Stage3 |
2.276400E-01 |
| Stage1-vs-Stage4 |
2.037200E-01 |
| Stage2-vs-Stage3 |
1.118410E-01 |
| Stage2-vs-Stage4 |
8.356000E-02 |
| Stage3-vs-Stage4 |
7.263000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.36599995151465E-09 |
| Normal-vs-AfricanAmerican |
5.395200E-03 |
| Normal-vs-Asian |
7.96240000044968E-07 |
| Caucasian-vs-AfricanAmerican |
3.280000E-01 |
| Caucasian-vs-Asian |
6.108200E-01 |
| AfricanAmerican-vs-Asian |
2.184200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.35760003239227E-09 |
| Normal-vs-Female |
1.65250000017103E-07 |
| Male-vs-Female |
6.556300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.67529999994809E-06 |
| Normal-vs-Age(41-60Yrs) |
7.90120002758243E-09 |
| Normal-vs-Age(61-80Yrs) |
1.58979999997921E-06 |
| Normal-vs-Age(81-100Yrs) |
1.862570E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.523600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.041600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.095200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.623600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.878600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.192800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.598400E-02 |
| Classical-VS-Follicular |
4.074000E-01 |
| Classical-VS-Other |
9.145800E-02 |
| Classical-VS-Normal |
3.7613000047898E-08 |
| Tall-VS-Follicular |
4.768000E-02 |
| Tall-VS-Other |
2.343000E-01 |
| Tall-VS-Normal |
1.50600000026202E-07 |
| Follicular-VS-Other |
9.964000E-02 |
| Follicular-VS-Normal |
4.791500E-04 |
| Other-VS-Normal |
3.603300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.16500000050202E-07 |
| Normal-vs-N1 |
3.37909999981179E-08 |
| N0-vs-N1 |
9.726500E-02 |
|
|
